MENU
CDTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cidara Therapeutics (CDTX) Ownership - Who owns Cidara Therapeutics?
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
6310 Nancy Ridge Drive
Phone
+1 858 752-6170
Employees
73
Web
https://www.cidara.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.61B
P/E Ratio
N/A
Total Cash
510.58M
Projected Growth
N/A
Total Debt
2.33M
Revenue
N/A
Risk (Beta)
1.32
Dividend Yield
N/A
Total Cash/Share
20.13
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CDTX
Capitalization
1.61B
P/E Ratio
N/A
Risk (Beta)
1.32
Dividend Yield
N/A
Total Cash
511M
Total Cash/Share
20.13
Total Debt
2.33M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
501M
P/B Ratio
3.21
Cash Flow
N/A
Earnings
-7.75
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
16.45
Current Revenue Per Employee
115931.51
Dividends Per Share - Security
N/A
EBITDA
-208.92M
Float
N/A
Float - Current
N/A
Gross Income Margin
81.53
Revenue To Assets
-33.20
Shares Held By Institutions
490M
Shares Outstanding - Current
25.4M
Total Liabilities
33.2M
Total Volume MTD
N/A
Value
-1
Gain YTD
135.975
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a developer of drugs for fungal infection
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
6310 Nancy Ridge Drive
Phone
+1 858 752-6170
Employees
73
Web
https://www.cidara.com